Tishkina A.; Mart’yanova E.; Logashina Y.; Andreev Y.; Khaibullina S.; Martynova E.; Rizvanov A.; Gulyaeva N.; Grishin E.
(2016)
© 2016, Pleiades Publishing, Ltd.Intranasal administration of the polypeptide APHC3, an antagonist of the TRPV1 receptor, had acute anxiolytic and antidepressant effects, as well as an ability to modify the microglial ...